JP2006504751A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006504751A5 JP2006504751A5 JP2004544592A JP2004544592A JP2006504751A5 JP 2006504751 A5 JP2006504751 A5 JP 2006504751A5 JP 2004544592 A JP2004544592 A JP 2004544592A JP 2004544592 A JP2004544592 A JP 2004544592A JP 2006504751 A5 JP2006504751 A5 JP 2006504751A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- hydrogen
- parathyroid
- lower alkyl
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C[C@](CCC[C@@](*)(*1)C1C[C@](*C(C[C@@](C(C)(C)C([C@@]1C)=O)O)=O)C(C)=Cc2c[s]c(*)n2)C1=O Chemical compound C[C@](CCC[C@@](*)(*1)C1C[C@](*C(C[C@@](C(C)(C)C([C@@]1C)=O)O)=O)C(C)=Cc2c[s]c(*)n2)C1=O 0.000 description 5
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41859202P | 2002-10-15 | 2002-10-15 | |
| PCT/IB2003/004514 WO2004035050A1 (en) | 2002-10-15 | 2003-10-13 | Use of epothilone derivatives for the treatment of hyperparathyroidism |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006504751A JP2006504751A (ja) | 2006-02-09 |
| JP2006504751A5 true JP2006504751A5 (enExample) | 2006-11-30 |
| JP4672368B2 JP4672368B2 (ja) | 2011-04-20 |
Family
ID=32107949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004544592A Expired - Fee Related JP4672368B2 (ja) | 2002-10-15 | 2003-10-13 | 副甲状腺機能亢進症の処置のためのエポシロン誘導体の使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20060142354A1 (enExample) |
| EP (1) | EP1553938B1 (enExample) |
| JP (1) | JP4672368B2 (enExample) |
| CN (1) | CN1297269C (enExample) |
| AT (1) | ATE350034T1 (enExample) |
| AU (1) | AU2003267751A1 (enExample) |
| BR (1) | BR0315293A (enExample) |
| CA (1) | CA2501717C (enExample) |
| CY (1) | CY1106385T1 (enExample) |
| DE (1) | DE60310975T2 (enExample) |
| DK (1) | DK1553938T3 (enExample) |
| ES (1) | ES2279139T3 (enExample) |
| PT (1) | PT1553938E (enExample) |
| SI (1) | SI1553938T1 (enExample) |
| WO (1) | WO2004035050A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| CA2496477C (en) | 2002-08-23 | 2012-10-16 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1155689E (pt) * | 1993-07-19 | 2007-01-31 | Angiotech Pharm Inc | Composições anti-angiogenicas e metodos de utilização |
| WO1998022461A1 (de) * | 1996-11-18 | 1998-05-28 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Epothilone c, d, e und f, deren herstellung und deren verwendung als cytostatische mittel bzw. als pflanzenschutzmittel |
| US6380394B1 (en) * | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
| KR20080016756A (ko) * | 1998-02-05 | 2008-02-21 | 노파르티스 아게 | 유기화합물 함유 조성물 |
| US6302838B1 (en) * | 1998-02-25 | 2001-10-16 | Novartis Ag | Cancer treatment with epothilones |
-
2003
- 2003-10-13 WO PCT/IB2003/004514 patent/WO2004035050A1/en not_active Ceased
- 2003-10-13 ES ES03748446T patent/ES2279139T3/es not_active Expired - Lifetime
- 2003-10-13 SI SI200330741T patent/SI1553938T1/sl unknown
- 2003-10-13 AT AT03748446T patent/ATE350034T1/de active
- 2003-10-13 US US10/530,855 patent/US20060142354A1/en not_active Abandoned
- 2003-10-13 AU AU2003267751A patent/AU2003267751A1/en not_active Abandoned
- 2003-10-13 JP JP2004544592A patent/JP4672368B2/ja not_active Expired - Fee Related
- 2003-10-13 PT PT03748446T patent/PT1553938E/pt unknown
- 2003-10-13 DE DE60310975T patent/DE60310975T2/de not_active Expired - Lifetime
- 2003-10-13 CA CA2501717A patent/CA2501717C/en not_active Expired - Fee Related
- 2003-10-13 BR BR0315293-6A patent/BR0315293A/pt not_active IP Right Cessation
- 2003-10-13 CN CNB200380101281XA patent/CN1297269C/zh not_active Expired - Fee Related
- 2003-10-13 EP EP03748446A patent/EP1553938B1/en not_active Expired - Lifetime
- 2003-10-13 DK DK03748446T patent/DK1553938T3/da active
-
2007
- 2007-03-15 CY CY20071100363T patent/CY1106385T1/el unknown
-
2011
- 2011-03-01 US US13/037,989 patent/US20110152329A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013501731A5 (enExample) | ||
| NZ527113A (en) | Rapid-onset medicament for the treatment of sexual dysfunction | |
| RU2006109467A (ru) | Способы лечения рака с использованием ингибиторов hdac | |
| JP2010500376A5 (enExample) | ||
| RU2000113729A (ru) | Гетероциклические соединения для ингибирования секреции желудочной кислоты, способы их получения и их фармацевтические компоозиции | |
| JP2009504763A5 (enExample) | ||
| JP2006523216A5 (enExample) | ||
| WO2010081817A1 (en) | Method for treating colorectal cancer | |
| JP2006506443A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2006503850A5 (enExample) | ||
| JP2008520544A5 (ja) | 癌関連疲労の治療または予防のための医薬の製造への使用方法 | |
| JP2006514092A5 (enExample) | ||
| JP2006507220A5 (enExample) | ||
| CA2671470A1 (en) | Powder formulation for valganciclovir | |
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| RU2010123028A (ru) | Кортикостероиды для лечения диареи, индуцированной эпотилоном или производным эпотилона | |
| JP2003519228A5 (enExample) | ||
| JP2020532562A5 (enExample) | ||
| ES2405323T3 (es) | Tratamiento de melanoma | |
| JPH10147529A5 (enExample) | ||
| EP4447973A1 (en) | Use of combination therapy for treating cancer | |
| US20160287549A1 (en) | Novel methods for treating neurodegenerative diseases | |
| CN103327975A (zh) | 用于治疗多形性成胶质母细胞瘤的含有马西替坦的组合物 | |
| JP2012525411A5 (enExample) |